StockData
Lisata Therapeutics, Inc. logo

Lisata Therapeutics, Inc. (LSTA) stock

LSTANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$0.98−0.06 (-5.76%)

Close on Nov 18, 2026Market cap $8.83MP/E –Yield –

Lisata Therapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Lisata Therapeutics's price to sales ratio was 109.4× on Nov 11, 2026, against 16.9× a year earlier. Over the last 5 years it ranged from 0.8× to 260.3×, with a median of 7.6×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 2026109.4×+94.2
2025Dec 31, 202515.2×+14.0
2018Feb 28, 20181.3×+0.3
2017Dec 29, 20170.9×+0.0
2016Dec 30, 20160.9×−3.1
2015Dec 31, 20154.0×−7.0
2014Apr 30, 201411.0×−41.4
2013Dec 31, 201352.3×+44.8
2012Dec 31, 20127.5×+6.3
2011Dec 30, 20111.2×–

More Lisata Therapeutics figures

See a number that looks wrong?